Objective-Sleep apnea (SA) has been linked with various forms of cardiovascular disease, but little is known about its association with peripheral artery disease (PAD) measured using the ankle-brachial index. This relationship was evaluated in the Hispanic Community Health Study/Study of Latinos. Approach and Results-We studied 8367 Hispanic Community Health Study/Study of Latinos participants who were 45 to 74 years of age. Sleep symptoms were examined with the self-reported Sleep Health Questionnaire. SA was assessed using an in-home sleep study. Systolic blood pressure was measured in all extremities to compute the ankle-brachial index. PAD was defined as ankle-brachial index <0.90 in either leg. Multivariable logistic regression was used to investigate the association between moderate-to-severe SA, defined as apnea-hypopnea index ≥15, and the presence of PAD. Analyses were adjusted for covariates. The prevalence of PAD was 4.7% (n=390). The mean apnea-hypopnea index was significantly higher among adults with PAD compared with those without (11.1 versus 8.6 events/h; P=0.046). After adjusting for covariates, moderate-to-severe SA was associated with a 70% increase in the odds of PAD (odds ratio, 1.7; 95% confidence interval, 1.1-2.5; P=0.0152). This association was not modified by sex (P=0.8739). However, there was evidence that the association between moderate-to-severe SA and PAD varied by Hispanic/Latino background (P<0.01). Specifically, the odds were stronger in Mexican (adjusted odds ratio, 2.9; 95% confidence interval, 1.3-6.2) and in Puerto Rican Americans (adjusted odds ratio, 2.0; 95% confidence interval, 0.97-4.2) than in other backgrounds. 
W
e recently reported the prevalence of mild, moderate, and severe sleep apnea (SA) in the US Hispanic/Latino population to be 25.8%, 9.8%, and 3.9%, respectively.
1 SA occurs when the upper airway collapses during sleep resulting in a cycle of hypoxemia, increased respiratory effort, frequent arousals, and increased sympathetic activity. The apnea-hypopnea index (AHI) is calculated as the sum of apneas and hypopneas per hour of sleep. Clinically significant SA is considered to be of at least moderate severity, defined as AHI ≥15 per hour.
SA is associated with cardiovascular morbidity and mortality and is an independent risk factor for coronary artery disease and stroke. [2] [3] [4] Atherosclerosis has been proposed as an intermediate between SA and incident cardiovascular disease events. 5 Numerous studies [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] have explored the relationship between SA and measures of atherosclerotic vascular disease in clinical or population-based samples. Such studies have examined the end point of carotid artery intimamedia thickness and reported a significant positive association between SA and increased carotid artery intima-media thickness. 5, [10] [11] [12] [13] [15] [16] [17] 21, 23, 24 Importantly, to our knowledge, no study to date has investigated the association between SA and the ankle-brachial index (ABI), an indicator of significant obstructive peripheral atherosclerotic burden in the lower extremities that independently predicts mortality. 25 To address the limitations of the current literature, we evaluated the association between SA and peripheral artery disease (PAD) among participants enrolled in the Hispanic Community Health Study/Study of Latinos. We also assessed the role of sex and Hispanic/Latino groups defined by place of birth or family background as potential effect modifiers of this association.
Material and Methods
Material and methods are available in the online-only Data Supplement.
Results
Among a total of 16 415 Hispanic Community Health Study/ Study of Latinos participants, those younger than 45 years of age were not assessed for ABI, resulting in exclusion of 6710 participants. Of the remaining participants, 1110 (6.76%) had missing or incomplete SA data, 39 (0.24%) had missing ABI data, and 189 (1.15%) had an ABI >1.4 in either or both legs. Therefore, the analytic sample for this study consisted of 8367 individuals.
The overall prevalence of PAD was 4.7% (n=390). Compared with those without PAD, participants with PAD were older (mean age, 61 versus 56 years; P<0.0001) and more often women (67% versus 55%; P=0.0001; Table 1 ). The mean body mass index was not significantly different between the 2 groups. As expected, the prevalence of comorbidities, such as hypertension, coronary heart disease (CHD), and diabetes mellitus were higher in the PAD group compared with the non-PAD group. Similarly, ≥10 pack-years of smoking history was more common in the group with PAD (39% versus 24%).
The mean AHI was significantly higher among adults with PAD compared with those without PAD (11.1 versus 8.6 events/h; P=0.046; Table 1 ). However, there was no statistically significant difference in self-reported sleep duration, mean baseline oxygen saturation, and mean sleep time spent with oxygen <90% between the 2 groups (data not shown). Table 2 shows the odds ratios (OR) from the multivariable model assessing the relationship between no to mild SA and moderate-to-severe SA (AHI≥15) to PAD. After adjusting for age, sex, body mass index, waist:hip ratio, hypertension, CHD, diabetes mellitus, dyslipidemia, C-reactive protein levels, smoking, alcohol use, physical activity, study site, and Hispanic/Latino background, individuals with moderate-tosevere SA were 1.67 (95% confidence interval [CI], 1.10-2.51) times more likely to have PAD. This association was not modified by sex (P=0.8739). However, there was evidence that the association between moderate-to-severe SA and PAD was different by Hispanic/Latino background (P<0.0001). Specifically, the odds were stronger in Mexican (adjusted OR, 2.9; 95% CI, 1.3-6.2) and in Puerto Rican Americans (adjusted OR, 2.02; 95% CI, 0.97-4.2) than in other backgrounds listed in Table 1 . The statistical power was inadequate to test this in other Hispanic/Latino groups.
Further analyses also assessed the relationship between increasing severity of SA and PAD (Table 3) . Here, the reference group consisted of individuals with an AHI<5. Three other categories reflecting increasing AHI severity were defined as 5 to <15 events/h, 15 to <30 events/h and ≥30 events/h. In an adjusted model, AHI 15 to <30 (moderate SA) was associated with a 90% increase in the odds of PAD as compared with AHI<5 (OR, 1.90; 95% CI, 1.15-3.14). The OR for AHI≥30, which defines severe SA, was not statistically significant but had a wide CI (versus AHI<5; OR, 1.21; 95% CI, 0.62-2.38).
We conducted a sensitivity analysis that excluded participants with prevalent CHD, and we found similar results (data not shown). We also assessed the independent relationship of PAD with sleep variables other than AHI. In a multivariate logistic regression model, there was no significant association between T90 and lowest oxygen saturation with PAD after adjustment for age, sex, study site, Hispanic background, income, physical activity, and C-reactive protein levels (data not shown).
Discussion
To our knowledge, this is the first study to assess the independent association between SA and PAD in a large communitybased cohort. We studied a diverse sample of Hispanics/Latinos, representing the largest minority population, residing within the United States. We found that the presence of moderate-to-severe SA was associated with a 67% increase in the odds of PAD, as measured by the ABI. These findings are independent of age, sex, body mass index, waist:hip ratio, hypertension, CHD, diabetes mellitus, dyslipidemia, C-reactive protein levels, smoking, alcohol use, physical activity, study site, and Hispanic/Latino background. The magnitude of this association was not modified by sex. Furthermore, the odds were stronger in Mexican and Puerto Rican Americans than in other backgrounds, reflecting either the play of chance or differences in prevalence and severity of these conditions across national backgrounds. No increase in risk of PAD was observed until an AHI of 15 was reached.
SA has been associated with numerous cardiovascular conditions, including hypertension, 26 CHD, 4,27 cardiac arrhythmias, 28 heart failure, 29, 30 stroke, 31 and sudden death. 32 Plausible mechanisms that may contribute to an overall increased vascular risk in the setting of SA include dyslipidemia, 33 40 and autonomic dysfunction. 41 Our study contributes to the literature linking SA with subclinical markers of vascular disease risk, which include several previous studies of the coronary and cerebrovascular beds. 6, 12, 18, 21, 42 SA is associated with increased carotid artery atherosclerosis and treatment of SA seems to decrease and reverse carotid artery atherosclerosis. 43, 44 Evidence also suggests that increasing severity of SA is independently associated with increased carotid artery plaque burden. 12, 17, 23, 42, 45 Similarly, current evidence suggests an independent link between SA and coronary artery atherosclerosis measured both invasively and noninvasively. However, until this study similar evidence for the association between SA and PAD was lacking. PAD affects ≈20% of individuals >60 years and can cause disabling symptoms because of claudication. 49 PAD is a marker of underlying atherosclerosis severity and prognosis, which shares many risk factors with SA, including hypertension, obesity, and diabetes mellitus. [50] [51] [52] A small study of patients with severe PAD who were awaiting surgical intervention reported a prevalence of undiagnosed SA of 85% (n=70/82). 53 This study had several limitations, including small sample size, lack of population-based study sample, and representation of the entire spectrum of PAD severity. In our study, PAD was assessed with the use of ABI, a noninvasive, reliable, inexpensive, and readily available technique that is typically used to diagnose subclinical and clinical PAD. More specifically, we used an abnormal ABI (<0.90) in either leg to indicate peripheral atherosclerosis, which compared with other non-invasive measures of atherosclerosis, typically requires more extensive burden of disease.
The Hispanic Community Health Study/Study of Latinos assessed SA with an in-home sleep study as opposed to in-laboratory full night attended polysomnography. This approach may modestly underestimate SA severity and does not allow assessment of sleep stages, duration, and fragmentation. Variation in recording times across individuals may have contributed to some misclassification of the AHI in cases when rapid eye movement sleep was not adequately represented. However, we found no association between recording time and either AHI or ABI (data not shown). Furthermore, our data are cross-sectional and, therefore, cannot establish a cause-effect relationship between SA and PAD. Adjustment for a full range of potential confounders nonetheless does not exclude the possibility of residual confounding.
We conducted a sensitivity analysis where we excluded prevalent CHD participants and we found similar results (data not shown). SA may, therefore, be associated with PAD independent of prevalent CHD. Our study was not designed to address the relative atherosclerotic effect of SA on different vascular beds, that is, coronary versus peripheral.
Future work is recommended to understand whether SA is worse for the peripheral arteries than coronary or carotid arteries.
In analyses of the dose-response relationship between SA severity and the odds of PAD (Table 3) , we did not All values are weighted to account for the complex survey design. SEs are in parenthesis. AHI indicates apnea-hypopnea index; BMI, body mass index; CHD, coronary heart disease; hsCRP, highly sensitive C-reactive protein; PA, physical activity; and PAD, peripheral arterial disease. Odds ratios are adjusted for all variables listed plus study site and Hispanic/ Latino background. AHI indicates apnea-hypopnea index; BMI, body mass index; CHD, coronary heart disease; hsCRP, highly sensitive C-reactive protein; PA, physical activity; PAD, peripheral arterial disease; and SA, sleep apnea.
find consistently increasing risk with increasing SA severity. Secondary analyses modeling AHI as categorical levels showed that the strongest association between SA and PAD was in the moderate SA group (OR, 1.90; 95% CI, 1.15-3.14). The lack of significant association in the severe SA group may have been because of the sample size limitations, which may be clarified in future studies about dose-response relationship.
Finally, we noted that Hispanic/Latino group seems to modify the relationship between SA and PAD, with stronger effects for Mexicans and Puerto Ricans relative to other backgrounds (Table 1 ). In our sample, Puerto Ricans had the highest prevalence of obesity (50.2%; SE, 2.32) when compared with the other Hispanic/Latino backgrounds, which may partly explain the stronger effects, noted in that group. The statistical power to explore the pattern of effect modification, however, was insufficient for the other backgrounds. We found no evidence that sex modified the relationship between SA and PAD.
This study included a population-based, rather than a referral or clinic-based sample, and thus is less influenced by selection biases than other cited research. 54 Our Hispanic/Latinos US study population has long been recognized to have high obesity risk and is now documented to have high prevalence of SA. 55 Previous studies evaluating the association between SA and subclinical peripheral atherosclerosis have not used the ABI, which is routinely available in a clinical setting and, therefore, is relatively accessible and at low cost.
Finally, the methods of measurement of SA and PAD were objective and standardized as part of this large multicenter National Institutes of Health-sponsored cohort study. Odds ratio is adjusted for age, sex, study site, Hispanic/Latino background, education, income, body mass index, pack years smoking, hypertension, coronary heart disease, diabetes mellitus, dyslipidemia, waist:hip ratio, physical activity, and highly sensitive C-reactive protein. AHI indicates apnea-hypopnea index; CI, confidence interval; PAD, peripheral arterial disease; and SA, sleep apnea.
